Donna Murray, co-director of the Kelly O'Leary Center for Autism Spectrum Disorders at Cincinnati Children's Hospital Medical Center, said that the study "continues to support the idea that we need to be able to provide more intensive early intervention" for autism spectrum disorders.
"We do know there are studies suggesting that applied behavioral analysis [used in the Denver model] has positive outcomes in children with autism," Murray said. "This is a very nice study to support what we had sort of suspected."
A second study published at the same time in Pediatrics found that the anti-psychotic drug aripiprazole (Abilify) helped quell tantrums, aggression and other forms of irritability in 98 children and adolescents with autism spectrum disorder. The study was funded by Bristol-Myers Squibb and Otsuka Pharmaceutical Co., which develop and market Abilify.
The drug is an antipsychotic more commonly used to treat schizophrenia and the mania associated with bipolar disorder.
The U.S. National Institute of Mental Health has more on autism spectrum disorders.
Copyright © 2011 HealthDay. All rights reserved.